1 Study Coverage
    1.1 Cobamamide Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Cobamamide Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Injection
        1.2.3 Tablets
    1.3 Market by Application
        1.3.1 Global Cobamamide Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Drug Store
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Cobamamide Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Cobamamide Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Cobamamide Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Cobamamide Drugs Sales by Region
        2.4.1 Global Cobamamide Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Cobamamide Drugs by Region (2023-2028)
    2.5 Global Cobamamide Drugs Revenue by Region
        2.5.1 Global Cobamamide Drugs Revenue by Region (2017-2022)
        2.5.2 Global Cobamamide Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Cobamamide Drugs Sales by Manufacturers
        3.1.1 Global Top Cobamamide Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Cobamamide Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cobamamide Drugs in 2021
    3.2 Global Cobamamide Drugs Revenue by Manufacturers
        3.2.1 Global Cobamamide Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Cobamamide Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Cobamamide Drugs Revenue in 2021
    3.3 Global Cobamamide Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Cobamamide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Cobamamide Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Cobamamide Drugs Sales by Type
        4.1.1 Global Cobamamide Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Cobamamide Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Cobamamide Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Cobamamide Drugs Revenue by Type
        4.2.1 Global Cobamamide Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Cobamamide Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Cobamamide Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Cobamamide Drugs Price by Type
        4.3.1 Global Cobamamide Drugs Price by Type (2017-2022)
        4.3.2 Global Cobamamide Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Cobamamide Drugs Sales by Application
        5.1.1 Global Cobamamide Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Cobamamide Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Cobamamide Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Cobamamide Drugs Revenue by Application
        5.2.1 Global Cobamamide Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Cobamamide Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Cobamamide Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Cobamamide Drugs Price by Application
        5.3.1 Global Cobamamide Drugs Price by Application (2017-2022)
        5.3.2 Global Cobamamide Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Cobamamide Drugs Market Size by Type
        6.1.1 North America Cobamamide Drugs Sales by Type (2017-2028)
        6.1.2 North America Cobamamide Drugs Revenue by Type (2017-2028)
    6.2 North America Cobamamide Drugs Market Size by Application
        6.2.1 North America Cobamamide Drugs Sales by Application (2017-2028)
        6.2.2 North America Cobamamide Drugs Revenue by Application (2017-2028)
    6.3 North America Cobamamide Drugs Market Size by Country
        6.3.1 North America Cobamamide Drugs Sales by Country (2017-2028)
        6.3.2 North America Cobamamide Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Cobamamide Drugs Market Size by Type
        7.1.1 Europe Cobamamide Drugs Sales by Type (2017-2028)
        7.1.2 Europe Cobamamide Drugs Revenue by Type (2017-2028)
    7.2 Europe Cobamamide Drugs Market Size by Application
        7.2.1 Europe Cobamamide Drugs Sales by Application (2017-2028)
        7.2.2 Europe Cobamamide Drugs Revenue by Application (2017-2028)
    7.3 Europe Cobamamide Drugs Market Size by Country
        7.3.1 Europe Cobamamide Drugs Sales by Country (2017-2028)
        7.3.2 Europe Cobamamide Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Cobamamide Drugs Market Size by Type
        8.1.1 Asia Pacific Cobamamide Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Cobamamide Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Cobamamide Drugs Market Size by Application
        8.2.1 Asia Pacific Cobamamide Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Cobamamide Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Cobamamide Drugs Market Size by Region
        8.3.1 Asia Pacific Cobamamide Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Cobamamide Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Cobamamide Drugs Market Size by Type
        9.1.1 Latin America Cobamamide Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Cobamamide Drugs Revenue by Type (2017-2028)
    9.2 Latin America Cobamamide Drugs Market Size by Application
        9.2.1 Latin America Cobamamide Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Cobamamide Drugs Revenue by Application (2017-2028)
    9.3 Latin America Cobamamide Drugs Market Size by Country
        9.3.1 Latin America Cobamamide Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Cobamamide Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Cobamamide Drugs Market Size by Type
        10.1.1 Middle East and Africa Cobamamide Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Cobamamide Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Cobamamide Drugs Market Size by Application
        10.2.1 Middle East and Africa Cobamamide Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Cobamamide Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Cobamamide Drugs Market Size by Country
        10.3.1 Middle East and Africa Cobamamide Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Cobamamide Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Haerbin Medisan
        11.1.1 Haerbin Medisan Corporation Information
        11.1.2 Haerbin Medisan Overview
        11.1.3 Haerbin Medisan Cobamamide Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Haerbin Medisan Cobamamide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Haerbin Medisan Recent Developments
    11.2 North China Pharmaceutical Group
        11.2.1 North China Pharmaceutical Group Corporation Information
        11.2.2 North China Pharmaceutical Group Overview
        11.2.3 North China Pharmaceutical Group Cobamamide Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 North China Pharmaceutical Group Cobamamide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 North China Pharmaceutical Group Recent Developments
    11.3 Chongqing Yaoyou Pharmaceutical
        11.3.1 Chongqing Yaoyou Pharmaceutical Corporation Information
        11.3.2 Chongqing Yaoyou Pharmaceutical Overview
        11.3.3 Chongqing Yaoyou Pharmaceutical Cobamamide Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Chongqing Yaoyou Pharmaceutical Cobamamide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Chongqing Yaoyou Pharmaceutical Recent Developments
    11.4 Sinopharm Group Rongsheng Pharmaceutical
        11.4.1 Sinopharm Group Rongsheng Pharmaceutical Corporation Information
        11.4.2 Sinopharm Group Rongsheng Pharmaceutical Overview
        11.4.3 Sinopharm Group Rongsheng Pharmaceutical Cobamamide Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Sinopharm Group Rongsheng Pharmaceutical Cobamamide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Sinopharm Group Rongsheng Pharmaceutical Recent Developments
    11.5 Hainan Star Pharmaceutical
        11.5.1 Hainan Star Pharmaceutical Corporation Information
        11.5.2 Hainan Star Pharmaceutical Overview
        11.5.3 Hainan Star Pharmaceutical Cobamamide Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Hainan Star Pharmaceutical Cobamamide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Hainan Star Pharmaceutical Recent Developments
    11.6 Hebei Zhitong Biopharmaceutical
        11.6.1 Hebei Zhitong Biopharmaceutical Corporation Information
        11.6.2 Hebei Zhitong Biopharmaceutical Overview
        11.6.3 Hebei Zhitong Biopharmaceutical Cobamamide Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Hebei Zhitong Biopharmaceutical Cobamamide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Hebei Zhitong Biopharmaceutical Recent Developments
    11.7 Jiangsu Jiuxu Pharmaceutical
        11.7.1 Jiangsu Jiuxu Pharmaceutical Corporation Information
        11.7.2 Jiangsu Jiuxu Pharmaceutical Overview
        11.7.3 Jiangsu Jiuxu Pharmaceutical Cobamamide Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Jiangsu Jiuxu Pharmaceutical Cobamamide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Jiangsu Jiuxu Pharmaceutical Recent Developments
    11.8 Jiuquan Dadeli pharmaceutical
        11.8.1 Jiuquan Dadeli pharmaceutical Corporation Information
        11.8.2 Jiuquan Dadeli pharmaceutical Overview
        11.8.3 Jiuquan Dadeli pharmaceutical Cobamamide Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Jiuquan Dadeli pharmaceutical Cobamamide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Jiuquan Dadeli pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Cobamamide Drugs Industry Chain Analysis
    12.2 Cobamamide Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Cobamamide Drugs Production Mode & Process
    12.4 Cobamamide Drugs Sales and Marketing
        12.4.1 Cobamamide Drugs Sales Channels
        12.4.2 Cobamamide Drugs Distributors
    12.5 Cobamamide Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Cobamamide Drugs Industry Trends
    13.2 Cobamamide Drugs Market Drivers
    13.3 Cobamamide Drugs Market Challenges
    13.4 Cobamamide Drugs Market Restraints
14 Key Findings in The Global Cobamamide Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Cobamamide Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Injection
    Table 3. Major Manufacturers of Tablets
    Table 4. Global Cobamamide Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Cobamamide Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Cobamamide Drugs Sales by Region (2017-2022) & (Kg)
    Table 7. Global Cobamamide Drugs Sales Market Share by Region (2017-2022)
    Table 8. Global Cobamamide Drugs Sales by Region (2023-2028) & (Kg)
    Table 9. Global Cobamamide Drugs Sales Market Share by Region (2023-2028)
    Table 10. Global Cobamamide Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Cobamamide Drugs Revenue Market Share by Region (2017-2022)
    Table 12. Global Cobamamide Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Cobamamide Drugs Revenue Market Share by Region (2023-2028)
    Table 14. Global Cobamamide Drugs Sales by Manufacturers (2017-2022) & (Kg)
    Table 15. Global Cobamamide Drugs Sales Share by Manufacturers (2017-2022)
    Table 16. Global Cobamamide Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Cobamamide Drugs Revenue Share by Manufacturers (2017-2022)
    Table 18. Cobamamide Drugs Price by Manufacturers (2017-2022) &(US$/g)
    Table 19. Global Cobamamide Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Cobamamide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cobamamide Drugs as of 2021)
    Table 21. Cobamamide Drugs Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Cobamamide Drugs Product Offered
    Table 23. Date of Manufacturers Enter into Cobamamide Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Cobamamide Drugs Sales by Type (2017-2022) & (Kg)
    Table 26. Global Cobamamide Drugs Sales by Type (2023-2028) & (Kg)
    Table 27. Global Cobamamide Drugs Sales Share by Type (2017-2022)
    Table 28. Global Cobamamide Drugs Sales Share by Type (2023-2028)
    Table 29. Global Cobamamide Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Cobamamide Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Cobamamide Drugs Revenue Share by Type (2017-2022)
    Table 32. Global Cobamamide Drugs Revenue Share by Type (2023-2028)
    Table 33. Cobamamide Drugs Price by Type (2017-2022) & (US$/g)
    Table 34. Global Cobamamide Drugs Price Forecast by Type (2023-2028) & (US$/g)
    Table 35. Global Cobamamide Drugs Sales by Application (2017-2022) & (Kg)
    Table 36. Global Cobamamide Drugs Sales by Application (2023-2028) & (Kg)
    Table 37. Global Cobamamide Drugs Sales Share by Application (2017-2022)
    Table 38. Global Cobamamide Drugs Sales Share by Application (2023-2028)
    Table 39. Global Cobamamide Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Cobamamide Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Cobamamide Drugs Revenue Share by Application (2017-2022)
    Table 42. Global Cobamamide Drugs Revenue Share by Application (2023-2028)
    Table 43. Cobamamide Drugs Price by Application (2017-2022) & (US$/g)
    Table 44. Global Cobamamide Drugs Price Forecast by Application (2023-2028) & (US$/g)
    Table 45. North America Cobamamide Drugs Sales by Type (2017-2022) & (Kg)
    Table 46. North America Cobamamide Drugs Sales by Type (2023-2028) & (Kg)
    Table 47. North America Cobamamide Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Cobamamide Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Cobamamide Drugs Sales by Application (2017-2022) & (Kg)
    Table 50. North America Cobamamide Drugs Sales by Application (2023-2028) & (Kg)
    Table 51. North America Cobamamide Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Cobamamide Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Cobamamide Drugs Sales by Country (2017-2022) & (Kg)
    Table 54. North America Cobamamide Drugs Sales by Country (2023-2028) & (Kg)
    Table 55. North America Cobamamide Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Cobamamide Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Cobamamide Drugs Sales by Type (2017-2022) & (Kg)
    Table 58. Europe Cobamamide Drugs Sales by Type (2023-2028) & (Kg)
    Table 59. Europe Cobamamide Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Cobamamide Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Cobamamide Drugs Sales by Application (2017-2022) & (Kg)
    Table 62. Europe Cobamamide Drugs Sales by Application (2023-2028) & (Kg)
    Table 63. Europe Cobamamide Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Cobamamide Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Cobamamide Drugs Sales by Country (2017-2022) & (Kg)
    Table 66. Europe Cobamamide Drugs Sales by Country (2023-2028) & (Kg)
    Table 67. Europe Cobamamide Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Cobamamide Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Cobamamide Drugs Sales by Type (2017-2022) & (Kg)
    Table 70. Asia Pacific Cobamamide Drugs Sales by Type (2023-2028) & (Kg)
    Table 71. Asia Pacific Cobamamide Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Cobamamide Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Cobamamide Drugs Sales by Application (2017-2022) & (Kg)
    Table 74. Asia Pacific Cobamamide Drugs Sales by Application (2023-2028) & (Kg)
    Table 75. Asia Pacific Cobamamide Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Cobamamide Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Cobamamide Drugs Sales by Region (2017-2022) & (Kg)
    Table 78. Asia Pacific Cobamamide Drugs Sales by Region (2023-2028) & (Kg)
    Table 79. Asia Pacific Cobamamide Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Cobamamide Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Cobamamide Drugs Sales by Type (2017-2022) & (Kg)
    Table 82. Latin America Cobamamide Drugs Sales by Type (2023-2028) & (Kg)
    Table 83. Latin America Cobamamide Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Cobamamide Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Cobamamide Drugs Sales by Application (2017-2022) & (Kg)
    Table 86. Latin America Cobamamide Drugs Sales by Application (2023-2028) & (Kg)
    Table 87. Latin America Cobamamide Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Cobamamide Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Cobamamide Drugs Sales by Country (2017-2022) & (Kg)
    Table 90. Latin America Cobamamide Drugs Sales by Country (2023-2028) & (Kg)
    Table 91. Latin America Cobamamide Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Cobamamide Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Cobamamide Drugs Sales by Type (2017-2022) & (Kg)
    Table 94. Middle East and Africa Cobamamide Drugs Sales by Type (2023-2028) & (Kg)
    Table 95. Middle East and Africa Cobamamide Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Cobamamide Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Cobamamide Drugs Sales by Application (2017-2022) & (Kg)
    Table 98. Middle East and Africa Cobamamide Drugs Sales by Application (2023-2028) & (Kg)
    Table 99. Middle East and Africa Cobamamide Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Cobamamide Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Cobamamide Drugs Sales by Country (2017-2022) & (Kg)
    Table 102. Middle East and Africa Cobamamide Drugs Sales by Country (2023-2028) & (Kg)
    Table 103. Middle East and Africa Cobamamide Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Cobamamide Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Haerbin Medisan Corporation Information
    Table 106. Haerbin Medisan Description and Major Businesses
    Table 107. Haerbin Medisan Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
    Table 108. Haerbin Medisan Cobamamide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Haerbin Medisan Recent Developments
    Table 110. North China Pharmaceutical Group Corporation Information
    Table 111. North China Pharmaceutical Group Description and Major Businesses
    Table 112. North China Pharmaceutical Group Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
    Table 113. North China Pharmaceutical Group Cobamamide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. North China Pharmaceutical Group Recent Developments
    Table 115. Chongqing Yaoyou Pharmaceutical Corporation Information
    Table 116. Chongqing Yaoyou Pharmaceutical Description and Major Businesses
    Table 117. Chongqing Yaoyou Pharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
    Table 118. Chongqing Yaoyou Pharmaceutical Cobamamide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Chongqing Yaoyou Pharmaceutical Recent Developments
    Table 120. Sinopharm Group Rongsheng Pharmaceutical Corporation Information
    Table 121. Sinopharm Group Rongsheng Pharmaceutical Description and Major Businesses
    Table 122. Sinopharm Group Rongsheng Pharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
    Table 123. Sinopharm Group Rongsheng Pharmaceutical Cobamamide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Sinopharm Group Rongsheng Pharmaceutical Recent Developments
    Table 125. Hainan Star Pharmaceutical Corporation Information
    Table 126. Hainan Star Pharmaceutical Description and Major Businesses
    Table 127. Hainan Star Pharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
    Table 128. Hainan Star Pharmaceutical Cobamamide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Hainan Star Pharmaceutical Recent Developments
    Table 130. Hebei Zhitong Biopharmaceutical Corporation Information
    Table 131. Hebei Zhitong Biopharmaceutical Description and Major Businesses
    Table 132. Hebei Zhitong Biopharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
    Table 133. Hebei Zhitong Biopharmaceutical Cobamamide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Hebei Zhitong Biopharmaceutical Recent Developments
    Table 135. Jiangsu Jiuxu Pharmaceutical Corporation Information
    Table 136. Jiangsu Jiuxu Pharmaceutical Description and Major Businesses
    Table 137. Jiangsu Jiuxu Pharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
    Table 138. Jiangsu Jiuxu Pharmaceutical Cobamamide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Jiangsu Jiuxu Pharmaceutical Recent Developments
    Table 140. Jiuquan Dadeli pharmaceutical Corporation Information
    Table 141. Jiuquan Dadeli pharmaceutical Description and Major Businesses
    Table 142. Jiuquan Dadeli pharmaceutical Cobamamide Drugs Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
    Table 143. Jiuquan Dadeli pharmaceutical Cobamamide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Jiuquan Dadeli pharmaceutical Recent Developments
    Table 145. Key Raw Materials Lists
    Table 146. Raw Materials Key Suppliers Lists
    Table 147. Cobamamide Drugs Distributors List
    Table 148. Cobamamide Drugs Customers List
    Table 149. Cobamamide Drugs Market Trends
    Table 150. Cobamamide Drugs Market Drivers
    Table 151. Cobamamide Drugs Market Challenges
    Table 152. Cobamamide Drugs Market Restraints
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cobamamide Drugs Product Picture
    Figure 3. Global Cobamamide Drugs Market Share by Type in 2021 & 2028
    Figure 3. Injection Product Picture
    Figure 4. Tablets Product Picture
    Figure 5. Global Cobamamide Drugs Market Share by Application in 2021 & 2028
    Figure 6. Hospital
    Figure 7. Drug Store
    Figure 8. Other
    Figure 9. Cobamamide Drugs Report Years Considered
    Figure 10. Global Cobamamide Drugs Sales 2017-2028 (Kg)
    Figure 11. Global Cobamamide Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Cobamamide Drugs Revenue 2017-2028 (US$ Million)
    Figure 13. Global Cobamamide Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Cobamamide Drugs Sales Market Share by Region (2017-2022)
    Figure 15. Global Cobamamide Drugs Sales Market Share by Region (2023-2028)
    Figure 16. North America Cobamamide Drugs Sales YoY (2017-2028) & (Kg)
    Figure 17. North America Cobamamide Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Cobamamide Drugs Sales YoY (2017-2028) & (Kg)
    Figure 19. Europe Cobamamide Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Cobamamide Drugs Sales YoY (2017-2028) & (Kg)
    Figure 21. Asia-Pacific Cobamamide Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Cobamamide Drugs Sales YoY (2017-2028) & (Kg)
    Figure 23. Latin America Cobamamide Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Cobamamide Drugs Sales YoY (2017-2028) & (Kg)
    Figure 25. Middle East & Africa Cobamamide Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Cobamamide Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Cobamamide Drugs in the World: Market Share by Cobamamide Drugs Revenue in 2021
    Figure 28. Global Cobamamide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Cobamamide Drugs Sales Market Share by Type (2017-2028)
    Figure 30. Global Cobamamide Drugs Revenue Market Share by Type (2017-2028)
    Figure 31. Global Cobamamide Drugs Sales Market Share by Application (2017-2028)
    Figure 32. Global Cobamamide Drugs Revenue Market Share by Application (2017-2028)
    Figure 33. North America Cobamamide Drugs Sales Market Share by Type (2017-2028)
    Figure 34. North America Cobamamide Drugs Revenue Market Share by Type (2017-2028)
    Figure 35. North America Cobamamide Drugs Sales Market Share by Application (2017-2028)
    Figure 36. North America Cobamamide Drugs Revenue Market Share by Application (2017-2028)
    Figure 37. North America Cobamamide Drugs Sales Share by Country (2017-2028)
    Figure 38. North America Cobamamide Drugs Revenue Share by Country (2017-2028)
    Figure 39. U.S. Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Cobamamide Drugs Sales Market Share by Type (2017-2028)
    Figure 42. Europe Cobamamide Drugs Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Cobamamide Drugs Sales Market Share by Application (2017-2028)
    Figure 44. Europe Cobamamide Drugs Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Cobamamide Drugs Sales Share by Country (2017-2028)
    Figure 46. Europe Cobamamide Drugs Revenue Share by Country (2017-2028)
    Figure 47. Germany Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 48. France Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Cobamamide Drugs Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Cobamamide Drugs Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Cobamamide Drugs Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Cobamamide Drugs Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Cobamamide Drugs Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Cobamamide Drugs Revenue Share by Region (2017-2028)
    Figure 58. China Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 61. India Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Cobamamide Drugs Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Cobamamide Drugs Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Cobamamide Drugs Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Cobamamide Drugs Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Cobamamide Drugs Sales Share by Country (2017-2028)
    Figure 73. Latin America Cobamamide Drugs Revenue Share by Country (2017-2028)
    Figure 74. Mexico Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Cobamamide Drugs Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Cobamamide Drugs Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Cobamamide Drugs Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Cobamamide Drugs Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Cobamamide Drugs Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Cobamamide Drugs Revenue Share by Country (2017-2028)
    Figure 83. Turkey Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 85. UAE Cobamamide Drugs Revenue (2017-2028) & (US$ Million)
    Figure 86. Cobamamide Drugs Value Chain
    Figure 87. Cobamamide Drugs Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed